TYRA-200

N/A

Report date: 2023/12/25 14:51:37

NME

Base Information

Drug NameTYRA-200

Drug Alias NameTYRA200TYRA-200

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFibroblast growth factor receptor 1 inhibitorsFibroblast growth factor receptor 2 inhibitorsFibroblast growth factor receptor 3 inhibitors

TargetsFibroblast growth factor receptor 2Fibroblast growth factor receptor 1Fibroblast growth factor receptor 3

Therapy Area/IndicationsSolid tumoursBile Duct NeoplasmsBiliary Tract Neoplasms +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesTyra Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesTyra Biosciences Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursBile Duct NeoplasmsBiliary Tract Neoplasms +[4]

Inactive IndicationsN/A

Other Information

ATC CodeN/A